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Enveloped viruses utilize the membranous compartments of the host cell for the assembly and budding of
new virion particles. In this report, we have investigated the biogenesis and trafficking of the envelope
glycoprotein (GP-C) of the Junı́n arenavirus. The mature GP-C complex is unusual in that it retains a stable
signal peptide (SSP) as an essential component in association with the typical receptor-binding (G1) and
transmembrane fusion (G2) subunits. We demonstrate that, in the absence of SSP, the G1-G2 precursor is
restricted to the endoplasmic reticulum (ER). This constraint is relieved by coexpression of SSP in trans,
allowing transit of the assembled GP-C complex through the Golgi and to the cell surface, the site of arenavirus
budding. Transport of a chimeric CD4 glycoprotein bearing the transmembrane and cytoplasmic domains of
G2 is similarly regulated by SSP association. Truncations to the cytoplasmic domain of G2 abrogate SSP
association yet now permit transport of the G1-G2 precursor to the cell surface. Thus, the cytoplasmic domain
of G2 is an important determinant for both ER localization and its control through SSP binding. Alanine
mutations to either of two dibasic amino acid motifs in the G2 cytoplasmic domain can also mobilize the G1-G2
precursor for transit through the Golgi. Taken together, our results suggest that SSP binding masks endogenous ER localization signals in the cytoplasmic domain of G2 to ensure that only the fully assembled,
tripartite GP-C complex is transported for virion assembly. This quality control process points to an important
role of SSP in the structure and function of the arenavirus envelope glycoprotein.
cells is initiated by GP-C binding to cell surface receptors
followed by endocytosis of the virion into smooth vesicles (2).
Although ␣-dystroglycan serves as a binding receptor for the
Old World arenaviruses (6), the receptor utilized by the major
New World group of arenaviruses is unknown (59). GP-Cmediated membrane fusion is activated upon acidification of
the maturing endosome (2, 7, 13, 14) to deposit the virion core
into the cell cytoplasm and initiate replication.
The arenavirus envelope glycoprotein complex consists of
three noncovalently associated subunits derived from the
GP-C precursor: in addition to the typical receptor-binding
(G1) and transmembrane fusion (G2) subunits, the complex
contains a stable signal peptide (SSP) subunit (4, 18, 65) (Fig.
1). The 58-amino-acid SSP is generated by the cellular signal
peptidase and subsequently myristoylated (65). The mature G1
and G2 subunits are generated upon cleavage by the cellular
SKI-1/S1P protease (1, 35, 38) in the early Golgi compartment
(3). This proteolytic maturation event is essential for membrane fusion activity. The arenavirus G2 is a member of the
class I group of viral fusion proteins (25, 64) that orchestrate
membrane fusion through the triggered formation of a stable
six-helix bundle core (references 16, 17, 32, and 63 and references therein).
A tripartite envelope glycoprotein complex is unusual
among viral envelope glycoproteins, and the role of the unique
arenavirus SSP subunit has not been fully defined. In the GP-C
complex, SSP exists as a transmembrane protein, likely in a
type II topology with an extended luminal C terminus (19, 23).
The N terminus is modified by myristoylation, which is important for efficient membrane fusion activity (65). Recombinant
GP-C constructs in which SSP is replaced by a conventional

Arenaviruses are endemic in rodent populations worldwide
(53), and infection can be transmitted to humans to cause
severe acute hemorrhagic fevers (44, 51). Recurring outbreaks
are common in regions of arenavirus endemicity, and therapeutic options to combat arenavirus infection are limited. Phylogenetic analyses divide the arenaviruses into the Old World
species, such as Lassa fever and lymphocytic choriomeningitis
(LCM) viruses, and the New World species, such as Junı́n and
Machupo viruses. Up to 300,000 infections with Lassa fever
virus occur annually in Africa (45), and outbreaks of New
World viruses in the Americas are sporadic but routine (51).
Recently, infections by LCM virus in transplant recipients have
been reported (8). In the absence of effective prophylaxis and
treatment, the hemorrhagic fever arenaviruses remain an urgent public health concern.
The arenaviruses are enveloped viruses whose genomes consist of two single-stranded RNA molecules, each of which
encodes the ambisense expression of two of the four viral
proteins (5, 9). The viral envelope glycoprotein (GP-C) is
translated from a genomic-sense mRNA generated from the
short (S) genomic RNA, whereas the nucleocapsid protein is
translated from the antigenomic-sense mRNA. Similarly, the
viral matrix protein (Z) and RNA-dependent RNA polymerase are encoded in an ambisense orientation by the long (L)
RNA. During biogenesis, arenaviral particles assemble and
bud at the plasma membrane (49, 60). Viral entry into target
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FIG. 1. Schematic representation of the Junı́n virus GP-C glycoprotein and G2 cytoplasmic domain sequences. Amino acids of the
Junı́n virus envelope glycoprotein are numbered from the initiating
methionine, and cysteine residues (|) and potential glycosylation sites
(Y) are marked. The SSP and SKI-1/S1P cleavage sites and the resulting SSP, G1, and G2 subunits are indicated. Within G2, the C-terminal
transmembrane (TM) and cytoplasmic (cyto) domains are shown, as
are the N- and C-terminal heptad repeat regions (light-gray shading).
A comparison of G2 cytoplasmic domain sequences among arenavirus
species is detailed below the schematic. Sequences include the New
World isolates Junı́n (D10072), Tacaribe (M20304), Pichindé
(U77601), Machupo (AY129248), and Sabiá (YP_089665) and Old
World isolates Lassa-Nigeria (X52400), Mopeia (M33879), and
LCMV-Armstrong (M20869). The sites used to generate truncations
in the Junı́n virus cytoplasmic tail are indicated by angle brackets and
dibasic amino acid sequences are underlined.

signal peptide do not undergo significant proteolytic maturation by the SKI-1/S1P protease (18, 65). In the Old World
Lassa fever arenavirus, this defect can be rescued by coexpression of SSP in trans (18).
In the present report, we examine the biogenesis of the
GP-C complex of the Junı́n virus, a member of the New World
Tacaribe complex of arenaviruses that is responsible for recurring outbreaks of hemorrhagic fever in the pampas grasslands
of Argentina. We show that SSP association is required for
transport of the G1-G2 precursor from the endoplasmic reticulum (ER) and thereby for proteolytic maturation in the Golgi.
In the absence of SSP, the G1-G2 precursor is constrained to
the ER by dibasic amino acid sequences in the cytoplasmic
domain of G2. Association with SSP overcomes this block to
permit transit of the fully assembled complex through the
Golgi and to the cell surface. Moreover, our studies suggest
that, in addition to modulating trafficking of GP-C, SSP association may also be important for the membrane fusion activity
of the GP-C complex. The unique roles for SSP in the arenavirus life cycle may suggest novel strategies towards the prevention and treatment of arenaviral disease.
MATERIALS AND METHODS
Molecular reagents, recombinant vaccinia viruses, and monoclonal antibodies.
The GP-C coding region from the pathogenic Junı́n virus strain MC2 (28) was
provided by Victor Romanowski (Universidad Nacional de La Plata, Argentina)
and introduced into the mammalian expression vector pcDNA3.1⫹ as described
previously (65). For trans-complementation studies (18), the CD4sp-GPC construct in which SSP was replaced by the conventional signal peptide of CD4 (65)
was coexpressed with an SSP construct in which a stop codon was introduced
following the C-terminal SSP amino acid T58 (SSP-term). A chimeric glycoprotein (CD4ecto) bearing the CD4 signal peptide and ectodomain fused to the
transmembrane and cytoplasmic domains of G2 was constructed using the human CD4 cDNA (41) obtained through the National Institutes of Health (NIH)
AIDS Research and Reference Reagent Program. Mutations were introduced by
QuikChange mutagenesis (Stratagene), and PCR was used to generate truncations and chimeric plasmids. For the cytoplasmic-domain truncation series and in
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a control cleavage-defective GP-C plasmid (cd-GPC) (65), a C-terminal 15amino-acid S-peptide (Spep) affinity tag (34) was introduced to facilitate biochemical analysis (65). All constructs were verified by DNA sequencing, and
three independent clones typically were tested to ensure consistent phenotypes.
Optimal expression of the Junı́n virus GP-C gene and its derivatives in Vero 76
cells was achieved using the bacteriophage T7 promoter of the pcDNA3.1 vector
and infection by a recombinant vaccinia virus expressing the T7 polymerase
(vTF7-3) (24). The vaccinia virus vCB21R-lacZ expressing the ␤-galactosidase
gene under the control of the T7 promoter was used in our analysis of cell-cell
fusion (47). These recombinant vaccinia virus reagents were provided by T.
Fuerst and B. Moss and C. Broder, P. Kennedy, and E. Berger, respectively,
through the NIH AIDS Research and Reference Reagent Program.
Mouse monoclonal antibodies (MAbs) QC03-BF11 (BF11) and GB03-BE08
(BE08) (54), directed against the G1 subunit of GP-C, were kindly provided by
Tom Ksiasek and Tony Sanchez (Special Pathogens Branch, CDC, Atlanta,
Georgia). The anti-CD4 ectodomain MAb SIM.2 (43, 48) was obtained
through the NIH AIDS Research and Reference Reagent Program.
Expression of GP-C and its derivatives. The glycoproteins were expressed and
characterized as previously described (64, 65). Briefly, Vero 76 cells were infected with the recombinant vaccinia virus vTF7-3 (24) at a multiplicity of 2 in
Dulbecco’s minimal essential medium containing 2% fetal bovine serum (FBS)
and 10 M cytosine arabinoside (araC) (31). After 30 min, the cells were washed
and transfected with the GP-C expression plasmid using Lipofectamine 2000
reagent (Invitrogen). Metabolic labeling using 32 to 50 Ci/ml of 35S-ProMix
(Amersham Pharmacia Biotech) was initiated 6 h posttransfection in methionine- and cysteine-free medium containing 10% dialyzed FBS and 10 M araC
and was continued for 12 to 16 h. Cultures were then washed in physiological
buffered saline (PBS) and lysed using cold Tris-saline buffer (50 mM Tris-HCl
and 150 mM NaCl, pH 7.5) containing 1% Triton X-100 nonionic detergent and
protease inhibitors (1 g/ml each of aprotinin, leupeptin, and pepstatin). The
expressed glycoproteins were isolated from cleared lysates by immunoprecipitation using either the G1-directed MAbs or the CD4-directed MAb SIM.2 and
protein A-Sepharose (Sigma). In some experiments, glycoproteins containing the
C-terminal Spep affinity tag were isolated using S-protein agarose (Novagen).
Isolated glycoproteins were deglycosylated using peptide:N-glycosidase F (PNGase
F; New England Biolabs). Proteins were analyzed by sodium dodecyl sulfatepolyacrylamide gel electrophoresis using NuPAGE 4 to 12% bis-Tris gels (Invitrogen) and the recommended sample buffer containing lithium dodecyl sulfate
and reducing agent. Molecular size markers included 14C-methylated Rainbow
proteins (Amersham Pharmacia Biotech). Radiolabeled proteins were imaged
using a Fuji FLA-3000G imager and analyzed using ImageGauge software (Fuji).
For immunoprecipitation of cell surface glycoproteins, monolayers of metabolically labeled cells were incubated with MAb BE08 or SIM.2 in ice-cold PBS
containing 2% FBS and 0.1% NaN3 for 2 h. Following extensive washing, cells
were resuspended by scraping in PBS and lysed as described above. Immune
complexes were isolated from cleared lysates using protein A-Sepharose.
Flow cytometry. Vero 76 cells expressing GP-C or its derivatives were labeled
using the G1-specific MAb BE08 (54) and a secondary fluorescein isothiocyanate-conjugated goat anti-mouse antibody (Jackson ImmunoResearch). CD4
was detected using a fluorescein isothiocyanate-conjugated mouse anti-CD4
MAb (BD Biosciences). Cells were subsequently stained using propidium iodide
(1 g/ml) and then fixed in 2% formaldehyde (64). Populations were analyzed
using a FACSCalibur flow cytometer and CellQuest software (BD Biosciences).
GP-C-mediated cell-cell fusion. The ␤-galactosidase fusion reporter assay (47)
was used to characterize the ability of the envelope glycoproteins to mediate
pH-dependent cell-cell fusion (64, 65). Briefly, Vero cells infected with vTF7-3
and expressing the envelope glycoprotein were cocultured with reporter cells
infected with vCB21R-lacZ, a recombinant vaccinia virus expressing ␤-galactosidase under the control of the T7 promoter. The reporter cells were obtained by
incubating Vero 76 cells with vCB21R-lacZ at a multiplicity of 2 and allowing the
infection to proceed overnight in the presence of 100 g/ml rifampin (31). The
GP-C-expressing cells and reporter cells were cocultured in medium containing
both araC and rifampin for 5 h and then subjected to a 30-min pulse of neutral
or acidic (pH 5.0) medium. ␤-Galactosidase expression is induced upon fusion of
the effector and reporter cells and was detected, after 5 h of continued cultivation
at neutral pH, in cell lysates (Tropix) using the chemiluminescent substrate
GalactoLite Plus (Tropix). Cell-cell fusion was quantified using a Tropix TR717
microplate luminometer.
Confocal microscopy. Cells expressing GP-C glycoproteins were harvested by
trypsinization 6 h after transfection and reseeded to 8-well chambered cover
glasses (Lab Tek II) in medium containing 10 M araC. After 18 h, cultures were
washed in PBS and fixed with 4% formaldehyde for 10 min at room temperature.
Following washing and quenching with 50 mM Tris (pH 7.4) in PBS, cultures
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were either permeabilized in PBS containing 0.1% Triton X-100 and blocked in
the same buffer containing 5% FBS (for intracellular staining) or simply blocked
in the absence of detergent (for cell surface staining). GP-C glycoproteins were
detected using the G1-directed MAb BF11 and an Alexa Fluor 488-conjugated
anti-mouse antibody (Molecular Probes) in the appropriate blocking buffer. The
Golgi marker giantin was detected using a rabbit polyclonal antiserum (Covance
Research Products) and an Alexa Fluor 568-conjugated anti-rabbit antibody
(Molecular Probes). Chambers were covered with Slow Fade Gold (Molecular
Probes) and visualized using an inverted Nikon TE-300 microscope. Fluorescence was examined using a Bio-Rad Radiance 2000 confocal laser scanning
microscope and images were merged using Lasersharp software (Bio-Rad).

RESULTS
SSP association is required for proteolytic maturation. The
arenavirus SSP is distinct from conventional signal peptides in
that it is retained as an essential subunit of the mature GP-C
envelope glycoprotein complex and mediates functions beyond
translocation of the nascent polypeptide to the ER (18, 20, 65).
We previously showed that a recombinant Junı́n virus GP-C
glycoprotein in which SSP was replaced by the conventional
signal peptide of human CD4 (CD4sp-GPC) was unable to
undergo efficient maturation by the SKI-1/S1P protease (65),
extending similar observations with GP-C of the Old World
Lassa fever virus (18). In this Old World virus, the deficiency in
proteolytic cleavage in the absence of SSP was reversed by
coexpression of SSP in trans (18).
To investigate the role of SSP in the proteolytic maturation
of the Junı́n virus GP-C, we determined whether the coexpression of SSP in trans could likewise rescue cleavage. In these
studies, the Junı́n virus CD4sp-GPC construct was cotransfected with the SSP-term plasmid encoding the 58-amino-acid
SSP. Optimal expression in Vero cells was dependent on T7
RNA polymerase provided by the recombinant vaccinia virus
vTF7-3 (24). Cells were metabolically labeled, and GP-C glycoproteins were immunoprecipitated using the G1-directed
MAb BE08 (54). Baseline studies were performed using the
native GP-C glycoprotein that included its endogenous SSP.
Expression of the native glycoprotein resulted in the isolation
of a 60-kDa G1-G2 precursor glycoprotein and a heterodisperse smear of G1 and G2 subunits (30 to 35 kDa) (Fig. 2A,
top panel). These mature subunits are best resolved following
deglycosylation by PNGase F to yield 22- and 27-kDa polypeptides, respectively (bottom panel). The G1 and G2 subunits
were absent upon expression of an SKI-1/S1P cleavage-defective glycoprotein (cd-GPC) (65). A GP-C precursor glycoprotein bearing SSP is often detected as a minor species, suggesting incomplete signal peptidase cleavage in transfected cells
(20, 23, 65). As previously reported (18, 20, 23, 65), SSP was
coprecipitated as part of the wild-type and cleavage-defective
GP-C complexes (Fig. 2A, top panel).
Expression of the CD4sp-GPC glycoprotein in the absence
of SSP generated the 60-kDa G1-G2 precursor (Fig. 2A, top
panel, ⫺SSP) and considerably lesser amounts of the cleaved
glycoproteins (bottom panel). By contrast, expression of SSP in
trans (⫹SSP) enabled efficient cleavage of the G1-G2 precursor glycoprotein to produce mature G1 and G2 subunits (bottom panel). The relative efficiency of proteolytic maturation of
CD4sp-GPC in trans was similar to that of the native GP-C
glycoprotein. Furthermore, SSP was coprecipitated with the
CD4sp-GPC complex (top panel). Thus, coexpression of SSP

FIG. 2. Coexpression of SSP in trans rescues SKI-1/S1P cleavage
and cell surface expression of the G1-G2 precursor. (A) Metabolically
labeled glycoproteins were immunoprecipitated using the G1-specific
MAb BE08 and separated on NuPAGE 4-to-12% bis-Tris gels. The
wild-type (GP-C) and SKI-1/S1P cleavage-defective (cd-GPC) glycoproteins are shown for comparison with the CD4sp-GPC construct
encoding the conventional signal peptide of human CD4. CD4sp-GPC
was expressed alone (⫺SSP) or with SSP (⫹SSP). In the bottom panel,
the glycoproteins have been treated with PNGase F to resolve G1 and
G2 polypeptides. The deglycosylated GP-C polypeptides reveal both
the G1-G2 precursor and, in SSP-containing constructs, the pre-GP-C
precursor (65); additional species that migrate more slowly than the
G1-G2 precursor and with the pre-GP-C precursor are likely products
of incomplete deglycosylation. cd-GPC contains a C-terminal S-peptide affinity tag and migrates slightly slower than the other G1-G2
precursors. Known GP-C species are labeled at left; minor unidentified
bands are also present. The 14C-labeled protein markers (Amersham
Biosciences) are indicated (in kilodaltons). (B) Cell surface expression
of GP-C in Vero cells was determined by flow cytometry using the
G1-specific MAb BE08 (54). The cell population was subsequently
stained using propidium iodide (1 g/ml) to exclude dead cells. Cells
were fixed using 2% formaldehyde and analyzed using a FACSCalibur
flow cytometer (BD Biosciences). The histograms plot cell number
(counts) versus the fluorescence intensity of MAb binding. Background staining of mock-transfected cells is shown to identify nonexpressing cells in the transfected cell populations.

appears to rescue wild-type assembly and proteolytic processing in the New World Junı́n virus CD4sp-GPC complex.
SSP rescues cell-cell fusion activity in trans. To determine
whether the trans-complemented complex was also able to
mediate pH-dependent membrane fusion, we cocultured cells
expressing GP-C glycoproteins with Vero target cells infected
with the fusion reporter vaccinia virus vCB21R-LacZ expressing the ␤-galactosidase gene under control of the T7 promoter
(47). In this assay, activation of GP-C-mediated membrane
fusion by acidic pH (5.0) results in syncytium formation between the effector and reporter cells and expression of ␤-galactosidase; the enzymatic activity is then monitored using a
chemiluminescent substrate (64). As shown in Fig. 3, pH-dependent cell-cell fusion is readily detected using the native
GP-C glycoprotein and absent in the cleavage-defective cdGPC mutant. Cells expressing the CD4sp-GPC glycoprotein in
the absence of SSP were unable to mediate cell-cell fusion
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FIG. 3. pH-dependent cell-cell fusion activity. pH-dependent fusion was detected using the recombinant vaccinia virus-based ␤-galactosidase reporter assay (47) as previously described (64, 65). ␤-Galactosidase activity was quantitated using the chemiluminescent substrate
GalactoLite Plus (Tropix). Relative light unit (RLU) measurements
from cultures treated at pH 5.0 are shown after subtraction of background levels from neutral-pH cultures (average background, 1,500
RLU). Control conditions are shown in the underlined bars at left
(mock, wild-type GP-C, and cd-GPC). Note that CD4sp-GPC constructs are bracketed in pairs (below the axis) representing the
absence (open bars) and presence (gray bars) of SSP. Some bars are
not discernible on the scale of the graph. All conclusions were replicated using X-Gal (5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside)
staining of parallel cocultures.

(Fig. 3, CD4sp, first of the bracketed pairs of bars). By contrast, coexpression of SSP reconstituted pH-dependent cellcell fusion activity in the trans-complemented CD4sp-GPC
complex (second of bracketed pairs of bars) to levels greater
than those seen with the native GP-C glycoprotein. Thus, expression of SSP in trans can fully restore membrane fusion
activity to the Junı́n virus G1-G2 precursor glycoprotein.
SSP association is required for exit from the ER. To investigate the role of SSP in the biogenesis of GP-C, we examined
the intracellular localization of the complex by confocal microscopy. In these experiments, Vero cells expressing the wildtype and CD4sp-GPC glycoproteins were fixed, permeabilized,
and immunochemically stained using the anti-G1 MAb BF11
(54) and an Alexa Fluor 488-conjugated secondary antibody.
Nonpermeabilized cells were similarly stained to detect GP-C
accumulation on the cell surface. As shown in Fig. 4, the native
GP-C glycoprotein accumulated in the ER and Golgi-like
perinuclear structures (GP-C, permeabilized) and on the cell
surface (GP-C, surface). Localization to the Golgi apparatus
was confirmed using a rabbit polyclonal antibody directed
against an integral Golgi membrane protein, giantin (40), and
a secondary Alexa Fluor 568-conjugated antibody. Colocalization of GP-C with the Golgi marker is visualized in yellow in
the merged images. Expression of CD4sp-GPC in the presence
of SSP resulted in a pattern of localization and transport to the
cell surface similar to that of native GP-C (Fig. 4, CD4sp,
⫹SSP). These findings highlight the reconstitution of the GP-C
complex upon trans complementation with SSP.
In the absence of SSP, however, the G1-G2 precursor of
CD4sp-GPC exhibited a diffuse reticulate pattern of intracel-
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lular expression consistent with retention in the ER (Fig. 4,
CD4sp, ⫺SSP). Notably absent was any concentration of GP-C
staining to a morphologically defined Golgi apparatus or specific colocalization with the antigiantin MAb (merged image).
The orange in the merged image likely reflects the spatial
coincidence of green and red fluorescence rather than specific
colocalization to a definable Golgi structure. Also absent was
any staining of CD4sp-GPC on the cell surface (surface). The
lack of transport to the cell surface is not due to the absence of
proteolytic cleavage per se, because the cleavage-site-defective
cd-GPC mutant is transported to the cell surface as the wildtype glycoprotein (not shown) (1, 35). Nor did we detect punctate staining in the ER that might suggest misfolding of the
G1-G2 precursor in the absence of SSP. The difference in
trafficking of the G1-G2 precursor to the Golgi in the presence
or absence of SSP likely accounts for the effect of trans complementation on proteolytic cleavage (Fig. 2A), consistent with
the activation of SKI-1/S1P protease in the cis-medial Golgi
compartment (10, 21).
Next, we examined the role of SSP in the transport of the
GP-C complex to the cell surface by using flow cytometry and
the G1-specific MAb BE08. In cell cultures transiently expressing the wild-type GP-C glycoprotein, a clear population of
GP-C-expressing cells was evident (Fig. 2B, top right). A comparison of cells expressing CD4sp-GPC in the presence or
absence of SSP revealed that the GP-C glycoproteins were
present on the cell surface only upon coexpression of SSP
(bottom panels). Cell surface accumulation of the trans-complemented CD4sp-GPC glycoprotein was comparable to that
of the native GP-C glycoprotein. Taken together, these results
demonstrate that SSP is essential for GP-C transport to the
Golgi and the cell surface. In the absence of SSP, the G1-G2
precursor is localized to the ER.
Transit of a CD4 chimera bearing G2 sequences. To further
investigate the role of the G2 subunit in ER localization and
the role of SSP in regulating transit to the cell surface, we
determined whether control by SSP and the G2 subunit might
be transferable to a heterologous cell surface protein. Because
the ectodomain of human CD4 forms a soluble and secreted
protein (11, 58), we fused the CD4 signal peptide and ectodomain to the transmembrane and cytoplasmic regions of G2.
In the CD4ecto construct, the C terminus of soluble CD4
(TPV372) (11) was spliced at the G2 ectodomain sequence
TPL420, three residues upstream of D424, that nominally defines the junction with the transmembrane domain.
Cells expressing the CD4ecto chimera or native CD4 were
metabolically labeled, and cell lysates were immunoprecipitated
using the anti-CD4 ectodomain MAb SIM.2. The CD4ecto chimera was expressed as a 55-kDa glycoprotein that comigrated
with native CD4 (Fig. 5A, left panel). Upon coexpression, SSP
was found to coprecipitate with CD4ecto (Fig. 5A, left panel).
This association was specific to G2 sequences in the CD4ecto
glycoprotein; SSP did not bind to native CD4 (when coexpressed) (not shown). Thus, the transmembrane and cytoplasmic domains of G2 are sufficient for SSP binding.
Importantly, transport of the CD4ecto chimera through the
Golgi apparatus and to the cell surface was dependent on
coexpression of SSP. As shown by immunochemical staining
using SIM.2 MAb and confocal microscopy (Fig. 4, CD4ecto,
permeabilized), the chimeric glycoprotein was largely con-
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FIG. 4. Intracellular and cell surface visualization of glycoproteins. Confocal images were obtained as described in Materials and Methods.
Permeabilized cells were stained in green using either the MAb BF11 (GP-C) or, for CD4ecto, SIM.2 (CD4). Golgi structures were identified using
a rabbit polyclonal antiserum and stained in red. Merged images (merge) were created using Lasersharp software. Nonpermeabilized cells (surface)
were stained in green using either MAb BF11 or SIM.2. The expressed glycoproteins are indicated in white letters superimposed on the leftmost
images. The top row depicts cells expressing native GP-C or mock-transfected cells (all infected with the recombinant vaccinia virus vTF7-3). In
subsequent rows, the glycoproteins were expressed either in the absence (⫺SSP) or presence (⫹SSP) of SSP. In some images, the Golgi apparatus
is vesiculated and dispersed, perhaps due to infection of the cells by vaccinia virus.

strained to the ER in the absence of SSP and failed to colocalize with the Golgi apparatus (⫺SSP). In addition, only trace
amounts of the CD4ecto glycoprotein were detected in the
absence of SSP on the cell surface, either through confocal
microscopy (Fig. 4, surface) or flow cytometry (Fig. 5B, ⫺SSP).
Thus, fusion to the G2 transmembrane and cytoplasmic
domains prevented transport of the CD4 ectodomain from
the ER.
By contrast, coexpression with SSP resulted in significant
localization of CD4ecto in the Golgi (Fig. 4, ⫹SSP) and expression on the cell surface (surface). Mobilization of the chimeric glycoprotein by SSP was confirmed by flow cytometry
(Fig. 5B, ⫹SSP). Furthermore, immunoprecipitation studies of
CD4ecto expression on the cell surface (Fig. 5A, right panel)
identified the surface moiety as the complex of CD4ecto and
SSP. Together, these findings demonstrated that the essential
elements of ER localization and its control by SSP binding can
be recapitulated in a chimeric CD4ecto glycoprotein bearing
the transmembrane and cytoplasmic domains of G2.

Analysis of C-terminal truncations in the G2 cytoplasmic
domain. Among transmembrane proteins that are retained in
the ER, specific localization signals are often encoded within
the cytoplasmic domain (references 22, 37, and 62 and references therein). In order to define the determinants in G2 that
are required for ER localization, we constructed a series of
C-terminal truncations in the cytoplasmic domain of G2. Three
arginine residues, spaced 4, 7, and 17 amino acids from the
nominal transmembrane domain, were used as endpoints in
the truncations (Fig. 1). These positively charged termini were
chosen to facilitate anchoring of the truncated CD4sp-GPC
glycoprotein in the membrane. The arginine codons were fused
to those encoding an S-peptide affinity tag (34) to facilitate
analysis of the G2 moiety (65). Metabolically labeled glycoprotein was isolated using the Spep affinity tag and S-protein
agarose (Novagen). The truncated CD4sp-GPC glycoproteins
(R448⌬, R451⌬, and R460⌬) were well expressed in Vero cells
yet failed to coprecipitate significant amounts of SSP (Fig. 6A,
top panel). Nonetheless, all three truncated glycoproteins were
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FIG. 5. The chimeric CD4 glycoprotein bearing the transmembrane and cytoplasmic domains of G2 requires SSP for transport to the
cell surface. (A) The chimeric CD4ecto construct was expressed alone
(⫺SSP) or with SSP (⫹SSP) and metabolically labeled. Intact cells
were incubated with the anti-CD4 MAb SIM.2 (43, 48) and the cell
surface glycoproteins were subsequently isolated from cleared cell
lysates using protein A-Sepharose (surface). Intracellular CD4ecto
glycoprotein was immunoprecipitated from the post-protein A-Sepharose supernatant using additional SIM.2 MAb (lysate). Mock- and
human CD4-transfected cells served as controls. Molecular size markers (in kilodaltons) are as described in the legend to Fig. 2A. (B) Flow
cytometry using SIM.2 MAb was otherwise performed as described in
the legend to Fig. 2B, and results are plotted similarly. The filled gray
(⫺SSP) and open (⫹SSP) histograms are overlaid.

subjected to SKI-1/S1P cleavage, in the presence or absence of
SSP, to produce truncated and affinity-tagged G2 moieties
(Fig. 6A, bottom panel). The relative migrations of the truncated G2 polypeptides correspond to their expected molecular
weights but cause them to overlap with the intact G1 polypeptide. The association between G1 and the truncated G2 subunits was separately confirmed by coimmunoprecipitation using a MAb directed to G1 (not shown). By contrast, similar
truncations in G2 of the Old World LCM virus were reported
to prevent SKI-1/S1P cleavage (35).
Flow cytometry was used to determine whether the truncated Junı́n virus glycoproteins were also transported to the
cell surface without SSP. As shown in Fig. 6B, all three truncation mutants were expressed on the cell surface in the absence of SSP, at levels comparable to the trans-complemented
CD4sp-GPC glycoprotein (Fig. 2B). Truncations in the context
of CD4ecto likewise enabled transport from the ER (not
shown). In the LCM virus (35), the truncated GP-C was also
expressed on the cell surface. Taken together, these results
suggest that amino acid sequences within the cytoplasmic domain of G2 are important in constraining the G1-G2 precursor
to the ER. The cytoplasmic region is also important for SSP
association.
We have demonstrated that GP-C glycoproteins bearing
truncations in the cytoplasmic domain of G2 can be proteolytically processed and transported to the cell surface in the
absence of SSP. Surprisingly, however, none of the truncated
complexes was able to mediate pH-dependent cell-cell fusion
(Fig. 3). It is possible that this failure may be due to insufficient
cleavage or transport of the truncated glycoproteins. Alternatively, the failure may reflect a requirement for either SSP or
the cytoplasmic domain of G2 for membrane fusion activity.
Dibasic amino acid sequences participate in ER localization. Sequence analysis of the G2 cytoplasmic domain revealed
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FIG. 6. Truncations to the cytoplasmic domain of G2 ablate SSP
binding yet enable transport to the cell surface. (A) The wild-type and
truncated CD4sp-GPC glycoproteins (R448⌬, R451⌬, and R460⌬)
were expressed alone (⫺SSP) or with SSP (⫹SSP). Metabolically labeled glycoproteins were precipitated using the C-terminal Spep affinity tag and S-protein agarose (Novagen) and analyzed as described
in the legend to Fig. 2. The G1 and G2 glycoproteins are best resolved
following deglycosylation with PNGase F (bottom). Note that the
truncated G2 moieties (⌬G2) migrate near the wild-type G1 polypeptide; coassociation between G1 and ⌬G2 was formally demonstrated by
immunoprecipitation using anti-G1 MAb BF11, which coprecipitated
⌬G2 (not shown). Although coprecipitation of SSP was markedly reduced with the truncated glycoproteins, trace amounts could be discerned upon darkening of the image (not shown). This low level of SSP
association is judged to be insignificant, as the properties of the truncated glycoproteins are independent of SSP coexpression. Molecular
size markers (in kilodaltons) are as described in the legend to Fig. 2A.
(B) Cell surface expression of the truncated glycoproteins was determined by flow cytometry as described in the legend to Fig. 2B, and
results are plotted similarly. Note that expression of the wild-type
CD4sp-GPC glycoprotein (gray histograms in all three panels) is compared with that of the truncations (open histograms), all in the absence
of SSP.

conserved motifs that may be involved in protein trafficking
and ER localization. In particular, dibasic amino acid sequences such as the canonical KKXX and RXR motifs are
widely utilized in the retrieval of transmembrane proteins to
the ER (see references 22, 37, and 62 and references therein).
The cytoplasmic domain of Junı́n virus G2 contains two related
dibasic sequences: KKPT479 and a C-terminal RRGH485. Variants of these sequences appear in other arenavirus G2 proteins
(Fig. 1). To assess the potential role of these sequences in ER
localization, we mutated the two basic amino acids at each site
to alanines, both individually (KK and RR glycoproteins) and
as the double mutant (KK/RR).
Immunoprecipitation studies of metabolically labeled
whole-cell lysates revealed that all of the mutant CD4sp-GPC
glycoproteins were able to associate with SSP (Fig. 7A, top
panel). Neither of the dibasic sequences was essential for SSP
binding. trans complementation with SSP enabled wild-type
levels of cell surface expression (Fig. 7B, ⫹SSP) and efficient
pH-dependent cell-cell fusion (Fig. 3), arguing against significant adverse effects of the mutations on overall protein folding.
In the absence of SSP, importantly, both the single and
double mutants were now capable of transport to the cell
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FIG. 7. Alanine mutations to dibasic amino acid motifs enable transport from the ER. (A) CD4sp-GPC constructs containing KK, RR, and
double KK/RR mutations were expressed alone (⫺SSP) or with SSP (⫹SSP). Metabolically labeled glycoproteins were immunoprecipitated and
analyzed as described in the legend to Fig. 2A. Molecular size markers (in kilodaltons) are as described in the legend to Fig. 2A. (B) Flow cytometry
was performed as described in the legend to Fig. 2B, and results are plotted similarly. Note that the top panels compare expression of the
CD4sp-GPC glycoprotein (gray histograms in all panels) with that of the mutants (open histograms) in the absence of SSP. Expression with SSP
is shown in the bottom panels.

surface. This phenotype was evident upon confocal microscopic analysis of nonpermeabilized cells (Fig. 4, surface), although specific localization in the Golgi was difficult to discern
(green and merged images). Flow-cytometric studies of cell
surface expression indicated that both the single and double
mutations provided modest, albeit significant, relief of ER
retention (Fig. 7B, ⫺SSP). Evidence for enhanced SKI-1/S1P
cleavage of the mutant glycoproteins was, however, difficult to
discern in whole-cell lysates, above the residual level of cleavage in the wild-type glycoprotein (Fig. 7A, bottom panel). It
is possible that the cleaved species in the wild-type G1-G2
glycoprotein reflect transient residence in the Golgi, prior to
retrieval to the ER. In the Old World Lassa fever virus glycoprotein, where cleaved products are not observed in the absence of SSP (18), retrieval of the G1-G2 precursor may be
more rapid. Nonetheless, mobilization of the mutant glycoproteins to the cell surface was consistently observed and distinct
from the strict intracellular retention seen with the wild-type
glycoprotein. Both KK and RR mutations appeared to be
comparably efficacious, and no synergy was observed in the
double KK/RR mutant. However, none of the mutant glycoproteins was able to mediate cell-cell fusion in the absence of
SSP (Fig. 3). This defect is not attributable to the amino acid
substitutions per se, as wild-type levels of fusion were restored
upon trans complementation with SSP.
To confirm that the mutations are sufficient for significant
mobilization of the G1-G2 precursor in the absence of SSP, we
examined the glycoprotein by immunoprecipitation from the
cell surface (Fig. 8). These experiments confirmed significant
expression of the dibasic sequence mutants on the cell surface

and demonstrated a preponderance of the proteolytically processed G1-G2 complex, reflecting access to the SKI-1/S1P protease in the Golgi. The efficiency of cleavage in the mutant
glycoproteins was relatively unaffected by the presence or absence of SSP (60% cleaved versus 40% cleaved, respectively).
Taken together, these studies identify the two dibasic amino

FIG. 8. Cell surface expression of dibasic amino acid motif CD4spGPC mutants. Intact cells expressing the constructs shown in Fig. 7
were incubated with the G1-specific MAb BE08, and the cell surface
GP-C glycoproteins were isolated from cleared cell lysates using protein A-Sepharose and deglycosylated. The relative amounts of G1, G2,
and G1-G2 precursor in each lane were quantitated from the phosphorimage using Image Gauge software (Fuji), and the efficiency of
cleavage was determined as the sum of G1 plus G2 relative to total of
all forms. Distortion of the SSP band is due to the detergents used in
PNGase F treatment. Molecular size markers (in kilodaltons) are as
described in the legend to Fig. 2A.
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acid sequences (KKPT479 and RRGH485) as important determinants of ER localization in the absence of SSP. Alanine
mutations at either or both of these sites result in partial relief
from ER retention and enable transport to the cell surface in
the absence of SSP. On the other hand, these mutations do not
completely obviate the requirement for SSP association in
transport of the G1-G2 precursor (Fig. 8). Quantitative analysis of the glycoproteins indicated that, whereas the mutations
were able to increase cell surface expression at least 10-fold,
coexpression of SSP resulted in an additional 10-fold increase
in all mutants, to the levels of the wild-type glycoprotein. These
findings are consistent with our results from confocal microscopy and flow cytometry studies (Fig. 4 and 7). Thus, constraints on the trafficking of the G1-G2 precursor include the
dibasic sequence motifs in the cytoplasmic domain of G2 but
also involve additional structural elements provided upon full
assembly with SSP.
DISCUSSION
The regulation of trafficking through intracellular membranous compartments is central to the biogenesis of membrane
glycoproteins (15, 22). Quality control mechanisms for protein
folding and assembly are proposed to operate through checkpoints on exit from the ER and through bidirectional transport
to and from the Golgi apparatus. Viruses make use of these
cellular pathways in the biosynthesis, assembly, and release of
new virion particles (15). In our studies, we have characterized
the biogenesis of the arenavirus envelope glycoprotein and the
requirement for tripartite assembly to enable transport of the
GP-C complex from the ER. Without the association of SSP,
the wild-type G1-G2 precursor remains localized to the ER.
We show that localization is mediated by the cytoplasmic domain of G2 and that the control of trafficking by SSP association is transferable to a chimeric CD4 molecule bearing the G2
transmembrane and cytoplasmic domains. Conversely, regulation of intracellular transport of the GP-C complex does not
require G1 or the ectodomain of G2.
Our studies demonstrate that ER localization is mediated in
part through dibasic amino acid sequences in the cytoplasmic
domain of G2. Alanine mutations to either of two dibasic
motifs provide partial relief from ER localization and enable
expression of the proteolytically cleaved G1-G2 complex on
the cell surface. Upon exit from the ER and transit through the
Golgi, the mutant G1-G2 precursor is now fully susceptible to
proteolytic maturation by SKI-1/S1P protease. Thus, absent
ER localization signals, the arenavirus GP-C precursor can
undergo proteolytic maturation much as do the precursor glycoproteins of other class I viral fusion proteins.
Dibasic amino acid sequences are known to mediate ER
localization through retrograde transport (retrieval) from the
Golgi (references 22, 37, and 62 and references therein). The
specific dibasic sequences we have identified as important for
ER localization in the Junı́n virus G2 glycoprotein do not
match precisely either of the canonical ER retrieval motifs:
the C-terminal KKXX or internal RXR sequences. Although
the internal KK sequence studied here is conserved among the
New World arenaviruses, the C-terminal RRXX sequence
shows considerable variation (Fig. 1). Among the Old World
viruses, only the C-terminal motif is identifiable. However,
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variants to the canonical motifs are also common in other
ER-localized transmembrane proteins (46, 55, 62) and the
efficiency of retention by these sequences is often highly context dependent (26, 57, 66). Many details regarding the mechanisms and molecular determinants involved in ER-Golgi trafficking remain unresolved.
It is noteworthy that a viral envelope glycoprotein destined
for the cell surface should encode an ER localization signal.
For cellular transmembrane proteins that traverse the Golgi
and beyond, dibasic ER localization motifs are commonly
found to control the assembly and trafficking of heteromultimeric membrane protein complexes (12, 33, 39, 42, 67; reviewed in references 22 and 46). These endogenous signals
prevent transport of the individual subunits and are overcome
upon assembly of the multimeric complex. This quality control
mechanism ensures that only the fully and properly assembled
complex is transported from the ER. In the biogenesis of the
Junı́n virus GP-C complex, we propose an analogous role for
SSP association—namely, to mask endogenous ER localization
signals in the cytoplasmic domain of G2 and thus enable transport of only the fully assembled tripartite complex.
This strategy for assembly-dependent control of viral envelope glycoprotein trafficking is likely not unique to the arenaviruses. The bunyavirus GC glycoprotein also contains a noncanonical basic amino acid cluster that may be involved in ER
localization (29). In these viruses, transport of GC from the ER
requires association with a second envelope glycoprotein, GN
(30, 36), which in turn retains the GC-GN complex in the Golgi
(27, 29, 56), the site of virus budding. Together, these observations highlight the use of cellular ER-Golgi trafficking mechanisms during the viral life cycle to control the assembly and
transport of multimeric envelope glycoprotein complexes.
Despite mutations that enable the transport of the G1-G2
complex in the absence of SSP, wild-type levels of trafficking
were not restored by point mutations to the dibasic amino acid
sequences or by truncations in the cytoplasmic domain (not
shown). It is possible that additional constraints on GP-C
transport lie within the transmembrane domain of G2. Moreover, it is likely that the association with SSP remains essential
for the integrity of the GP-C complex. The SSP subunit has
uniquely evolved within the arenaviruses for purposes other
than simply to relieve ER retention of an envelope glycoprotein precursor. It is telling, then, that despite the accumulation
of cleaved G1-G2 complex on the cell surface, none of the
glycoproteins lacking SSP is able to mediate membrane fusion
(Fig. 3). Notably, GP-C glycoproteins bearing mutations at the
dibasic amino acid motifs are unable to promote fusion in the
absence of SSP yet are restored to full activity by coexpression
of SSP. This defect in fusion is likely not due to the lower levels
of cell surface glycoprotein in the absence of SSP, as robust
fusion is observed with comparably low levels of cleaved wildtype glycoprotein (see Fig. 6 of reference 64). Rather, we
suggest that SSP may be directly involved in modulating
pH-dependent membrane fusion by the GP-C complex.
In addition, the G1-G2 complex lacking SSP is not myristoylated. GP-C complexes in which myristoylation is blocked
by a G2A mutation are less able to mediate cell-cell fusion
than the wild-type glycoprotein (65), perhaps due to alterations
in trafficking to specific membrane microdomains (52, 61). The
G2A glycoprotein, however, retains 30% of the wild-type
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fusion activity, significantly more than the present G1-G2 complexes in the absence of SSP. This comparison suggests defects
beyond the lack of acylation in G1-G2 complexes lacking SSP.
Separately, myristoylation may also be important during virion
assembly in facilitating the colocalization of GP-C with the
myristoylated Z matrix protein (50).
Further studies will no doubt delineate the additional roles
of the unique SSP subunit in the arenavirus life cycle. Unique
solutions embodied in the assembly, trafficking, and membrane
fusion activity of the arenavirus GP-C complex may suggest
novel approaches for intervention towards the prevention and
treatment of arenavirus hemorrhagic fevers.
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